Arbutus Biopharma Q3'26 Earnings Preview: Revenue Estimate Provided
Arbutus Biopharma is scheduled to report Q3'26 results on November 11. EPS is anticipated at $(0.02); the report time is unspecified.
ABUS (Arbutus Biopharma Corporation) is set to announce its Q3'26 results on November 11, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 1.00 million USD with EPS (earnings per share) anticipated at (0.02) USD. Learn more de…